Biosafety classification is based on U.S. Public Health Service Guidelines, it is the responsibility of the customer to ensure that their facilities comply with biosafety regulations for their own country.
Cells from W++ mouse bone marrow were cloned by limiting dilution to obtain the W-20-17 cell line. Ref
Thies RS. Recombinant human bone morphogenetic protein-2 induces osteoblastic differentiation in W-20-17 stromal cells. Endocrinology 130: 1318-1324, 1992. PubMed: 1311236

Thies RS. Recombinant human bone morphogenetic protein-2 induces osteoblastic differentiation in W-20-17 stromal cells. Endocrinology 130: 1318-1324, 1992. PubMed: 1311236
Thies RS. Recombinant human bone morphogenetic protein-2 induces osteoblastic differentiation in W-20-17 stromal cells. Endocrinology 130: 1318-1324, 1992. PubMed: 1311236Cells used in the W-20-17 assay should not be carried in continuous culture. A working cell bank should be prepared with approximately 5?x 105 cell/mL. Cells should be thawed before each assay.
Recombinant human bone morphogenetic protein-2 (rhBMP-2) increased alkaline phosphatase activity in W-20-17 cells in a dose-responsive manner without an effect on proliferation.?Ref
Thies RS. Recombinant human bone morphogenetic protein-2 induces osteoblastic differentiation in W-20-17 stromal cells. Endocrinology 130: 1318-1324, 1992. PubMed: 1311236
Bone morphogenetic protein-3 (BMP-3) was unable to induce an osteogenic response in W-20-17 cells. Ref
Thies RS. Recombinant human bone morphogenetic protein-2 induces osteoblastic differentiation in W-20-17 stromal cells. Endocrinology 130: 1318-1324, 1992. PubMed: 1311236?
Subcultivation Ratio: 1:4 to 1:6
Medium Renewal: At subculture.
Note: For more information on enzymatic dissociation and subculturing of cell lines consult Chapter 10 in Culture of Animal Cells, a Manual of Basic Technique by R. Ian Freshney, 3rd edition, published by Alan R. Liss, N.Y., 1994.
Wang W, et al. Ski represses bone morphogenic protein signaling in Xenopus and mammalian cells. Proc. Natl. Acad. Sci. USA 97: 14394-14399, 2000. PubMed: 11121043
Thies RS. Recombinant human bone morphogenetic protein-2 induces osteoblastic differentiation in W-20-17 stromal cells. Endocrinology 130: 1318-1324, 1992. PubMed: 1311236
Alden TD, et al. In vivo endochondral bone formation using a bone morphogenetic protein 2 adenoviral vector. Hum. Gene Ther. 10: 2245-2253, 1999. PubMed: 10498255
Bahamonde ME, Lyons KM. BMP3: to be or not to be a BMP.. J. Bone Joint Surg. Am. 83-A: S56-S62, 2001. PubMed: 11263666
Standard Test Method for In Vitro Biological Activity of Recombinant Human Bone Morphogenetic Protein-2 (rhBMP-2) Using the W-20 Mouse Stromal Cell Line. West Conshohocken, PA:ASTM International;ASTM Standard Test Method F 2131-02 (Reapproved 2007)e1.
Hay, R. J., Caputo, J. L., and Macy, M. L., Eds. (1992), ATCC Quality Control Methods for Cell Lines. 2nd edition, Published by ATCC.
Caputo, J. L., Biosafety procedures in cell culture. J. Tissue Culture Methods 11:223-227, 1988.
Fleming, D.O., Richardson, J. H., Tulis, J.J. and Vesley, D., (1995) Laboratory Safety: Principles and Practice. Second edition, ASM press, Washington, DC.
